We started Hippocratic AI with a clear mission: to fundamentally transform healthcare by safely harnessing the power of generative AI to improve access, equity, and outcomes. Today, I’m proud to announce that we’ve closed a $53M Series A funding round at a $500M valuation.
Since our founding last year, we have proven our ability to build an LLM for healthcare that is safer and more effective than general-purpose generative AI models. Today, the company also released its first product for phase three safety testing: a staffing marketplace for healthcare where health systems, payors, and others can “hire” generative AI agents that complete low-risk, non-diagnostic, patient-facing healthcare tasks to help solve the massive shortage of healthcare nurses, social workers, nutritionists, and other healthcare professionals.
These new funds will be used to accelerate further product development and conduct phase three safety testing for its LLM and the world’s first generative AI-powered healthcare agents that can unlock ‘Super-Staffing’ for healthcare and improve outcomes for patients and providers alike.
Importantly, though, generative AI must be developed and deployed safely and responsibly to make a real positive impact. I can confidently say that our investors – Premji Invest - US, General Catalyst, SVA and Memorial Hermann Health System, as well as existing investors a16z Bio + Health, share our deep commitment to ‘do no harm’ and focus on responsible innovation.
Thank you to our backers and our 40+ leading healthcare partners for believing in us and our vision. Together, we are looking forward to ushering in the next era of healthcare abundance for all.
Learn more about our new funding and what it will be used for here